[Rinsho ketsueki] The Japanese journal of clinical hematology

Keyphrases

Publications

volume 64, number 8, 2023

Isamu Kubota, Shun Nagasawa, Midori Nakagawa, Ai Yamada, Mariko Kinoshita, Sachiyo Kamimura, Hidemi Shimonodan, Hiroshi Moritake
[Successful treatment of eltrombopag following immunosuppressive therapy in pediatric aplastic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (8) (2023)
Junko Takita
[Molecular mechanisms of pediatric intractable leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (8) (2023)

volume 64, number 9, 2023

Yuji Shimura
[Immune suppressive cells in the tumor microenvironment of multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yuho Najima
[Breakthroughs in FLT3-mutated acute myeloid leukemia treatments]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Shigeki Ito
[Optimization of treatment strategy for relapsed or refractory multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yoshihiro Inamoto
[Adenovirus disease after hematopoietic cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Weijia Zang, Wataru Saika, Yumi Aoyama, Daichi Inoue
[Hematological malignancies driven by aberrant splicing]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Shun-Ichi Kimura
[Invasive candidiasis after hematopoietic cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Makoto Yoshimitsu
[Adult T-cell leukemia/lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Kentaro Watanabe
[Characteristics and management of leukoencephalopathy in leukemia treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Hideyo Hirai
[Human diseases and the mechanisms regulating myelopoiesis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Jun-Ichi Nishimura
[Novel therapeutic agents for hemolytic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Junya Kanda
[Clinical significance of human leukocyte antigen incompatibility in allogeneic hematopoietic stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Hisashi Kato
[Recent progress in immune thrombocytopenia pathophysiology and treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yoshiyuki Takahashi, Nobuhiro Nishio
[Chimeric antigen receptor (CAR) T cells targeting CD19 for acute lymphoblastic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yoshiaki Kuroda
[Infection risks and prevention in patients with multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Hideki Goto
[Management of adverse effects in CAR T-cell therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Nobuhiro Tsukada
[Updated treatment strategy for transplant-eligible multiple myeloma: current status and future perspectives]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yoshiyuki Ogawa
[Diagnosis and treatment of autoimmune acquired coagulation factor deficiency]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Daisuke Ennishi
[Pathobiology and its clinical relevance in diffuse large B-cell lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Daisuke Shinoda
[Pathogenic role of insufficiency of polycomb repressive complex in primary myelofibrosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Tomomasa Yokomizo
[Hematopoietic system formation during embryogenesis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Kohei Hosokawa
[Immune pathophysiology of bone marrow failure]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yosuke Tanaka, Toshio Kitamura
[Novel therapeutic strategy for targeting chronic myeloid leukemia stem cells via IRAK1/4 inhibition]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Kensuke Kojima
[Biological and clinical significance of TP53 mutations in myelodysplastic syndrome and acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Takayuki Ikezoe
[Prophylaxis and treatment of hematological malignancy-associated thrombosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Mayuko Iijima
[Neurocognitive function of acute lymphoblastic leukemia survivors treated only with chemotherapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Tatsu Shimoyama
[Current and future perspectives on CAR-T cell therapy to adult malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Masayoshi Kobune
[Diagnosis and treatment of anemia by malnutrition in the elderly]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Hirokazu Kanegane, Dan Tomomasa, Kay Tanita
[Hematopoietic cell transplantation for monogenic inflammatory bowel disease]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Seitaro Terakura
[Selection strategy for graft source in 2023]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Tomoya Muto
[Role of innate immune signaling and inflammation in the pathogenesis of myeloid malignancies]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Noriko Fukuhara
[Treatment strategies for follicular lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Koji Nagafuji
[Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in the first complete remission]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Tomofumi Yamamoto, Yusuke Yamamoto
[Extracellular vesicle-mediated drug resistance in multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Hirohito Yamazaki
[Reference guide for the treatment of aplastic anemia: key points of the 2022 revision]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Mamiko Sakata-Yanagimoto
[Applications of single-cell analysis in blood research]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Izumi Yanatori
[An overview of iron metabolism and new insights into the role of ferritin secretion]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Akihiro Tomita
[Usefulness of liquid biopsy technology in clinical practice of malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Minami Yamada-Fujiwara
[Understanding and management of adverse transfusion reactions]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Naoto Takahashi
[Next treatment for TKI-resistant CML]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Shouichi Ohga, Naoki Egami, Taeko Hotta, Takeshi Uchiumi, Masayuki Ochiai, Masataka Ishimura
[Genetic predisposition to early-onset thrombophilia: a study on challenges in personalized medicine for mothers, infants, and children]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Ritsuro Suzuki
[The correct way to read and understand published clinical trial results]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yozo Nakazawa
[Immune cell therapy for acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Keiyo Takubo
[Imaging techniques for the bone marrow environment]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Motoshi Ichikawa
[Current state of treatment for myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Yoko Edahiro
[Novel therapeutics in myeloproliferative neoplasms: beyond JAK inhibitors]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Takahiro Yamada
[Medical ethics in genomic medicine]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Masanori Matsumoto
[Novel treatment strategies for acquired thrombotic thrombocytopenic purpura]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)
Kenichi Yoshida
[Myeloid neoplasms with germline predisposition]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64 (9) (2023)